IBI Nightingale to design Birmingham Women's Hospital

By Admin
Share
Written by Katie Endicott Over the coming months, the Practice will be working with the Trust to deliver their Outline Business Case to be submitted f...

Written by Katie Endicott

 

Over the coming months, the Practice will be working with the Trust to deliver their Outline Business Case to be submitted for approval.

Birmingham Women’s NHS Foundation Trust (BWFT) is a leading provider of healthcare services in the West Midlands, offering a range of services to around 50,000 women and men a year.

“The design of the VITA Project will enable BWHT to build on its excellent reputation and grow and deliver services, including: maternity, neonatal, genetics, laboratory, gynaecology and fertility,” said Professor Ros Keeton, Chief Executive of Birmingham Women's NHS Foundation Trust. “Working in partnership with IBI Nightingale we will design a hospital that delivers excellent healthcare, education, training and research, contributing to the health and wellbeing of the people of the West Midlands and beyond.”

The VITA Project will redevelop the Birmingham Women Hospital site to allow all services to adopt new clinical practices, respond to increasing projected demand and enable replacement of unsuitable accommodation with first-class healthcare facilities.

“We share the Trust’s vision and fully recognize the potential to create a healthcare facility that defines Birmingham Women’s Hospital as an inspiring place to work and an exceptional facility to receive specialist care,” said Martha McSweeney, Harwell Office Principal.

The Trust went out to market for a full design team in September. IBI Nightingale’s response was to seamlessly combine its in-house healthcare planning service into its architectural offering, something the Trust saw as a winning formula.

“Our ability to provide an experienced, integrated team gave BWHT the confidence that we will build a robust Business Case.  By matching the design solution to the service model we will provide a scheme they can confidently take forward,” said Paul Whittlestone, IBI Global Lead for Healthcare Strategy.

Work starts immediately to submit the OBC by July 2014.

About IBI Nightingale:
IBI Nightingale is a leading architectural practice specialising in the fields of health, education and science. 
A member of IBI Group, IBI Nightingale has six studios in the UK.
A commitment to innovation and research has placed IBI Nightingale at the forefront of design developments in areas such as modern learning environments, primary and mental healthcare, sustainable design and laboratory planning.  
Website: www.ibi-nightingale.com    

About IBI Group

IBI Group is a global architecture, planning, engineering and technology firm. We are building the cities of today and planning the cities oftomorrow … on five continents. We are global designers of local communities.

Since our founding in 1974, IBI Group has grown both organically and through strategic acquisitions. Today we are fourth largest architectural firm in the world, based in 80 offices located around the world and employing more than 3,000 professionals and support staff. 

IBI Nightingale and IBI Taylor Young are members of the IBI Group of firms.

In the UK, we have offices in: London, Oxford, Cardiff, Brighton, Rochdale, Handforth, Liverpool, Glasgow, Newark, and Birmingham.
Website: www.ibigroup.com    

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma